These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4613464)

  • 1. Clinical application of the pharmacokinetics of procaine amide.
    Koch-Weser J
    Cardiovasc Clin; 1974; 6(2):63-75. PubMed ID: 4613464
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic of procainamide in man.
    Koch-Weser J
    Ann N Y Acad Sci; 1971 Jul; 179():370-82. PubMed ID: 5285382
    [No Abstract]   [Full Text] [Related]  

  • 3. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 4. The clinical use of procainamide.
    Miller RR; Greenblatt DJ
    Am J Hosp Pharm; 1974 Sep; 31(9):889-91. PubMed ID: 4607729
    [No Abstract]   [Full Text] [Related]  

  • 5. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
    Anderson JL
    Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Certain problems of antiarrhythmia therapy in myocardial infarct].
    Sivkov II; Kukes VG; Mamedova AD; Rozinov IuI; Maziĭ SA
    Sov Med; 1974 Nov; (11):58-64. PubMed ID: 4439076
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensible prescribing. II--What happens to all the pills they swallow?
    Rawlins MD
    Practitioner; 1975 Feb; 214(1280):274-81. PubMed ID: 1144254
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pharmacokinetics and metabolism of flunitrazepam].
    Amrein R
    Klin Anasthesiol Intensivther; 1978; (17):8-24. PubMed ID: 28445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Procain amide and phenytoin as anti-arrhythmia agents, some dosage principles].
    Karlsson E
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1198-200. PubMed ID: 4839996
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract]   [Full Text] [Related]  

  • 11. Experiences on a sustained-release procainamide preparation.
    Ruosteenoja R; Torsti P; Sothmann A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure.
    Giardina EG; Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1973 Feb; 78(2):183-93. PubMed ID: 4683748
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Time-dependent effect of oral procainamide in patients with exertional arrhythmias.
    Levy RH; Gey GO; Bruce RA
    J Pharm Sci; 1974 Dec; 63(12):1958-9. PubMed ID: 4449032
    [No Abstract]   [Full Text] [Related]  

  • 14. A new sustained-release tablet formulation of procainamide.
    Fremstad D; Dahl S; Jacobsen S; Lunde PK; Nådland KJ; Marthinsen AA; Waaler T; Landmark KH
    Eur J Clin Pharmacol; 1973 Dec; 6(4):251-5. PubMed ID: 4591152
    [No Abstract]   [Full Text] [Related]  

  • 15. Procaine amide against re-entrant ventricular arrhythmias. Lengthening R-V intervals of coupled ventricular premature depolarization as an insight into the mechanism of action of procaine amide.
    Giardina EG; Bigger JT
    Circulation; 1973 Nov; 48(5):959-70. PubMed ID: 4270892
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of procainamide therapy after cardiac infarction.
    Royds R; Shaw TR; Kumana CR; Padgham D; Hamer J
    Br Heart J; 1973 Aug; 35(8):862-3. PubMed ID: 4729848
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
    Hoffman BF; Rosen MR; Wit AL
    Am Heart J; 1975 Jun; 89(6):804-8. PubMed ID: 1130271
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic prophylaxis in acute myocardial infarction.
    Koch-Weser J
    N Engl J Med; 1971 Oct; 285(18):1024-5. PubMed ID: 4937689
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.
    Arstila M; Katila M; Sundquist H; Anttila M; Pere E; Tikkanen R
    Acta Med Scand; 1974 Mar; 195(3):217-22. PubMed ID: 4595254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.